Thursday, April 23, 2026
33.2 C
Bengaluru

National Seminar on UCPMP

National Seminar on Uniform Code of Pharmaceutical Marketing Practices (UCPMP) - Karnataka Drug and Pharmaceutical Producers Association (KDPMA)

Theme: “Building Brands – Building a Future”

Friday, 16 September 2016 | Hotel Lalit Ashok, Kumara Krupa Road, Bangalore (Google Maps)


Seminar Objectives

The seminar will help companies especially Product Management Teams and Sales Teams to understand their changing roles due to UCPMP. It will also bring clarity on strategies and promotional inputs including CME’s, sampling, gifts etc. Part of deliberation will also cover monitoring and implementation of UCPMP. The eminent speakers will also share their perspective on the future of brand building in the post-UCPMP era.


Keynote Speaker

  • Shri. Sudhansh Pant, IAS – Joint Secretary, Dept. of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India

Speakers

  • Dr. Ganesh Nayak – Executive Director and CEO, Zydus Cadila Ltd.
  • Anup Soans – Editor, MedicinMan
  • Samir Rai – National Sales Manager, Meyer Organics (Sales and Marketing, in charge of 4 divisions.)
  • Dr. H. N. Ravindra – Executive Committee Member, Indian Medical Council, New Delhi

Registration

Download the registration form below and mail to the address mentioned within.

[wpfilebase tag=file id=81 tpl=thumbnail target=blank/]

 

 

 

Hot this week

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation

The story of Healthium is not just one of...

Topics

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...
spot_img

Related Articles

spot_imgspot_img